1 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Efficacy and Safety of Rifaximin-α in Treating MASLDmetabolic dysfunction-associated steatotic liver diseaseRecruitingEarly phase 12026-02-02NCT07381257